PCVAX | VISVX | PCVAX / VISVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 27 years | - |
Gain YTD | 11.646 | 14.945 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 316M | 63B | 1% |
Annual Yield % from dividends | 2.15 | 1.90 | 113% |
Returns for 1 year | 3.73 | 16.18 | 23% |
Returns for 3 years | -7.11 | 20.58 | -35% |
Returns for 5 years | -2.46 | 52.67 | -5% |
Returns for 10 years | -43.73 | 105.07 | -42% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EXHAX | 25.83 | N/A | N/A |
Manning & Napier Pro-Blend Max Term S | |||
VKSEX | 10.85 | N/A | N/A |
Virtus KAR Small-Mid Cap Value C | |||
CIAOX | 46.30 | -0.16 | -0.34% |
Capital Advisors Growth Investor | |||
FMUAX | 14.97 | -0.07 | -0.47% |
Federated Hermes Muni and Stock Adv A | |||
ESPCX | 35.17 | -0.43 | -1.21% |
Allspring Special Small Cap Value C |